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Liesnard suggests a different and more expensive strategy than Table 1. Comparison of comorbidities among 53 elderly and 82
younger adult patients with infective endocarditis.vaccination of persons with isolated anti-HBc, which would in-
volve multiple serologic tests for HBV markers, alanine amino-
No. (%) of patientstransferase (ALT), and testing for HBV DNA. Liesnard bases this
strategy on the possibility that HBV DNA is demonstrated in a
Elderly patients Younger patients
minority of persons with isolated anti-HBc and also on the concern
Condition (n  53) (n  82) P value
that hepatitis B vaccine in persons who are HBV DNA positive
could induce the emergence of surface antigen escape mutants. Cardiac risk factors 22 (42) 49 (60) .04
These mutants have been previously described primarily in infants Bicuspid aortic valve 1 (2) 10 (12) .02
of HBs antigen–positive mothers who are given both hepatitis B Congenital vitium 0 (0) 7 (9) .03
Diabetes mellitus 7 (13) 12 (15) NSimmunoglobulin (HBIG) and hepatitis B vaccine, and are thought
Renal insufficiency onto be selected for primarily by HBIG and not by vaccine [3]. These
admission 19 (36) 12 (15) .005mutants should be detected by use of PCR using primers from the
Malignancy 12 (23) 6 (7) .02core region, since the mutations are only in the surface gene.
Immunosuppression 0 (0) 3 (4) NSBecause we found HBV DNA in only 4% of our study population
and we used primers from the core region as well as the surface
region, it is highly unlikely that a significant proportion of our
population of anti-HBc positive persons is infected with these
endocarditis (Duke criteria) and no history of intravenous drugsurface gene mutant HBV viruses. Furthermore, we do not advo-
abuse, who have been hospitalized in our tertiary-care institutioncate the administration of HBIG to adults with anti-HBc only.
between 1980 and 1995. We excluded all patients who were 60–Therefore, we stand by our proposed strategy to vaccinate persons
64 years of age to detect age-related differences in two distinctwith anti-HBc only.
groups of patients. Of the remaining 135 patients, 82 could be
assigned to the group of younger patients (17–59 years of age)
Brian J. McMahon and Alan J. Parkinson and 53 to the group of elderly patients (65–90 years of age).
Alaska Native Medical Center and Arctic Investigations Program, In a systematic retrospective chart review, we analyzed multiple
Centers for Disease Control and Prevention, Anchorage, Alaska
demographic, clinical, echocardiographic, and treatment-related
parameters to evaluate age-related differences in clinical presenta-
References tion and factors associated with outcome.
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ciency at admission and malignancy were significantly more com-Bisceglie AM. Hepatitis B virus DNA in persons with isolated antibody
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Fever 50 (94) 76 (93) NS
Neurological symptoms 23 (43) 28 (34) NS
Splenomegaly 10 (19) 33 (40) .01Native Valve Infective Endocarditis in Elderly and
Heart failure 27 (51) 31 (38) NS
Younger Adult Patients: Comparison of Clinical Features Valvular surgery 16 (30) 33 (40) NS
and Outcomes with Use of the Duke Criteria ECC duration (min) 101 91 NS
Post-interventional complications 14 (88) 14 (42) .003
Arrhythmias 12 (75) 13 (39) .02SIR—We read with interest the article by Gagliardi et al. [1],
Necessity of reoperation 7 (64) 3 (23) .05comparing clinical features and mortality in 108 elderly and
Embolic events 24 (45) 46 (56) NS
younger patients with native valve infective endocarditis, defined
Anticoagulant therapy 32 (60) 39 (48) NS
by the Duke criteria [2], and no history of intravenous drug abuse. Cerebral deficit on discharge 2 (5) 6 (8) NS
Because we have applied the same evaluation criteria to our Death 13 (25) 9 (11) .04
database of patients with infective endocarditis, we would like to
NOTE. ECC  extra-corporeal circulation.report our findings on 155 patients with native valve infective
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Table 3. Age-controlled predictors of mortality among patients with our analysis adds an element of caution with respect to valve
infective endocarditis: logistic regression analysis of in-hospital com- replacement surgery, as the procedure is prone to more frequent
plications and predictors of death. complications in this patient group.
Complication OR 95% CI P value
Roman O. M. Netzer, Esther Zollinger, Christian Seiler, and
Andreas CernyCardiac risk factors 0.6 0.3–1.1 .47
Division of Cardiology and Department of Internal Medicine, UniversityRenal insufficiency 1.8 0.5–7.2 .39
Hospital, Inselspital Bern, SwitzerlandCNS infection 2.5 0.4–14.0 .31
Age 1.0 0.6–6.1 .30
Pulmonary embolism 6.2 0.4–151.8 .23
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In contrast to the patients studied by Gagliardi et al., the duration
of hospitalization was not greater in our group of elderly patients
Replythan in younger patients (mean, 35 vs. 36 days). However, for
several factors not reported by Gagliardi et al. we found significant
differences between the two age groups. Older patients were sig- SIR—We agree that the results reported by Netzer et al. are basi-
cally similar to the data we reported concerning the presentation,nificantly more prone to complications after valvular surgery in
general (i.e., prosthetic dysfunction, pericardial tamponade, and clinical course, and outcome of infective endocarditis (IE) in
younger and elderly patients with native valve endocarditis [1].renal insufficiency), and, particularly, rhythm disturbances, as well
as the necessity for a second intervention (table 2). For younger However, a few differences between their results and ours are
notable. Netzer et al. found that splenomegaly occurred in a higherpatients, known cardiac comorbidities were significantly more
common, especially bicuspid aortic valve and congenital vitia in proportion of their younger patients with IE. The presence or ab-
sence of splenomegaly was not recorded for all of the patientsgeneral (table 1). The same was true for the frequency of vascular
phenomena at admission and splenomegaly (table 2). Sites of val- included in our analysis; therefore, we were unable to compare
our data on this potentially important finding with theirs.vular involvement were significantly different in the two age
groups. While in the elderly the mitral valve was predominantly Some differences between our results and those of Netzer et al.
may reflect differences in patient selection. Our study arbitrarilyaffected (52%), the aortic valve was the site of infection for 55%
of younger patients (P  .006). defined patients aged 30–59 years as a ‘‘younger adult group’’
[1]; Netzer et al. included patients aged 17–59 years in theirIn-hospital mortality was higher in the elderly and in patients
with renal insufficiency according to univariate analysis, but this younger adult cohort. Twenty-one percent of the younger patients
reported by Netzer et al. had congenital valvular abnormalities,difference was no longer significant after logistic regression analy-
sis had been performed (table 3). The only independent risk factor including 12% with bicuspid aortic valves. We found no statisti-
cally significant differences in location of valvular involvementfor adverse outcome was neurological deficit during infective en-
docarditis. between younger and elderly adult patients [1].
Netzer et al. reported that elderly patients were at greater riskAs expected, and in accordance with the report by Gagliardi et
al., we found no relevant differences in symptoms and signs of for postoperative complications. This finding is both important and
consistent with our general clinical experience and common sense,infective endocarditis in the two age groups and a predominance
of comorbidities in elderly patients. However, the distribution of but we did not specifically examine this point in our study because
our original database did not include follow-up information for allaffected valves was significantly different between the two groups.
We can confirm the finding by Gagliardi et al. that age is not patients [1].
Since 1996, we have prospectively collected data from allan independent predictor of adverse outcome, while neurological
deficit is. Although this finding supports early and aggressive treat- patients suspected of having IE at Duke University Medical
Center (Durham, North Carolina). Follow-up information wasment of native valve infective endocarditis in elderly patients,
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